curriculum vitae and bibliography kenneth r olivier, md · curriculum vitae and bibliography...
Post on 25-May-2020
10 Views
Preview:
TRANSCRIPT
Kenneth R Olivier, MDCurriculum Vitae and Bibliography
Present Academic Rank and PositionConsultant - Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota
08/2011 - Present
Vice Chair for Education - Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota
04/2013 - Present
Residency Program Director - Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota
07/2013 - Present
Professor of Radiation Oncology - Mayo Clinic College of Medicine and Science 04/2017 - Present
CertificationBoard Certifications
American Board of Radiology (ABR)
Radiation Oncology 2002 - Present
Mayo Clinic Quality Academy
Mayo Clinic Quality Fellow: Bronze Level Certification 2011
Additional Education
Clinical Interventional OncologyPanel member for case presentations in Liver and Lung tumorsMiami, Florida
01/2015 - 02/2015
EducationHope College - BA, Business Administration and Psychology 1988 - 1990
Wayne State University School of Medicine - MD 1993 - 1997
Butterworth Hospital - Internship 1997 - 1998
Mayo Graduate School of Medicine, Mayo Clinic College of Medicine - Resident, Radiation Oncology
1998 - 2002
Personal InformationPlace of Birth: Grand Rapids, MI
Citizenship: United States of America
Work Address: Mayo Clinic Rochester200 First St SWRochester, MN 55905-0001
Email Address: Olivier.Kenneth@mayo.edu
RE-AIMS 09/15/2017
LicensureFlorida ME95432 (Medical) 03/2006 - PresentWisconsin 52327 (Medical) 10/2008 - 2015Minnesota 41035 (Medical) 11/2008 - Present
Previous Professional Positions and Major AppointmentsAssociate Consultant - Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota
09/2002 - 03/2004
Instructor in Oncology - Mayo Clinic College of Medicine and Science 01/2003 - 03/2004
Assistant Professor in Radiation Oncology - University of Florida, Gainesville, Florida
2004 - 2008
Assistant Professor - University of Florida, Gainesville, FloridaAssistant Professor of Radiation Oncology at the University of Florida in Gainesville.
07/2004 - 08/2008
Senior Associate Consultant - Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota
08/2008 - 08/2011
Assistant Professor in Radiation Oncology - Mayo Clinic College of Medicine and Science
04/2010 - 08/2011
Associate Professor in Radiation Oncology - Mayo Clinic College of Medicine and Science
09/2011 - 03/2017
Professional Memberships and Services
Aesculapians
Professional and Community Memberships, Societies, and Services
Honors and Awards
Cum Laude - Hope College - Present
Honors for Year III of medical school - Wayne State University 01/1995 - 01/1996
Student Representative to AAMC - Wayne State University 01/1995 - 01/1997
Penfield Award - Wayne State University 01/1997
Top 20% of graduating class - Wayne State University 01/1997
Moreton Fellow - Mayo Graduate School of Medicine, Mayo Clinic College of Medicine
01/2001 - 01/2002
K-12 , Davenport fellow - Mayo Graduate School of Medicine, Mayo Clinic College of Medicine
01/2002 - 01/2003
Resident Research Award - Radiological Society of North America 01/2002
Teacher of the year in Radiation Oncology - University of Florida 01/2006
Excellence in Teaching - University of Florida 01/2007
Teacher of the Year - Mayo Fellows Association, Mayo School of Graduate Medical Education, Mayo Clinic College of Medicine, Rochester, Minnesota
2010
RE-AIMS 09/15/2017
Kenneth R Olivier, MD Page 2 of 23
MemberAid to Impaired Medical Students
Student Member 08/1996 - 06/1997American Board of Radiology
Volunteer 03/2007 - PresentAmerican College of Radiology
Site Representative 07/2014 - PresentAssociation of American Medical Colleges
Student Representative 01/1995 - 01/1997Chaplain's Executive Committee
Member 08/1990 - 12/1990National Institutes of Health
Radiation Therapy Oncology GroupRTOG Steering Committee for Lung Cancer
Member 01/2003 - 06/2013University of Florida
Clinic Improvement CommitteeMember 01/2007 - Present
Healthcare Safety CommitteeMember 01/2008
Protocol Review and Resource UtilizationMember 01/2007 - Present
Radiation Oncology Chair searchMember 01/2007 - Present
UpToDateEditor of Website 05/2015 - Present
Journal Editorial Responsibilities
Frontiers in Radiation OncologyAssociate Editor 01/2011 - Present
Journal Other Responsibilities
American Journal of Clinical Oncology
Reviewer
Cancer
Reviewer
Chest
Reviewer
Head and Neck
Community Memberships and Services
Committee for Accreditation of Medical Physics Education ProgrampsReviewer 01/2006 - Present
Journal Responsibilities
RE-AIMS 09/15/2017
Kenneth R Olivier, MD Page 3 of 23
Reviewer
International Journal of Radiation Oncology Biology and Physics
Reviewer
Journal of Thoracic Oncology
Reviewer 06/2010 - Present
Practical Radiation Oncology
Reviewer 08/2013 - Present
Radiation Therapy and Oncology
Reviewer
Curriculum and Course Development
Professional Mentoring for Radiation OncologyMonthly lectures to the residents in Radiation Oncology given over a 2 year period. Topics are related to professional development in Radiation Oncology
Radiobiology reviewReviewed Radiobiology with residents in Radiation OncologyUniversity of FloridaGainesville, Florida
04/2004 - 07/2008
Mayo Clinic Radiation Oncology: Current Practice and Future DirectionsProgram Co-Director for first SAM course for department
Hawaii
01/2016 - 01/2016
Educational Activities
RE-AIMS 09/15/2017
Kenneth R Olivier, MD Page 4 of 23
Teaching Intramural
Stereotactic Body Radiotherapy for Non-Small Cell Lung CancerMayo Clinic
CNS malignanciesSchool of Radiotherapy at Mayo ClinicRochester, Minnesota
2000 - 2001
Radiation Oncology Basicsto Medical OncologyUniversity of FloridaGainesville, Florida
2004 - 2008
Radiation for Lung Cancerto Pulmonary MedUniversity of FloridaGainesville, Florida
2004 - 2008
The Lymphomasto UF MSIIUniversity of FloridaGainesville, Florida
2004 - 2008
Lung Cancerto UF MSIIUniversity of FloridaGainesville, Florida
2004 - 2008
Radiobiologyto Radiation Oncology residentsUniversity of FloridaGainesville, Florida
2005 - 2008
Myeloma and PlasmacytomasOncology Core CurriculumMayo Clinic Core CurriculumRochester, Minnesota
2008
Lung SBRTMayo Clinic Core Curriculum
2012
Mentorship
Chera, Bisham (Radiation Oncology Resident)Description: Current Status: Outcome:
01/2004
Chopra, Rahul (Medical Student)Description: Current Status: Outcome:
01/2004
RE-AIMS 09/15/2017
Kenneth R Olivier, MD Page 5 of 23
Chang, Daniel (Radiation Oncology Resident)Description: Current Status: Outcome:
01/2004 - 01/2006
Walsh, Kathy (Internal Medicine Resident)Description: Current Status: Outcome:
01/2005 - Present
Byer, Gracie (Undergraduate Student)Description: Current Status: Outcome:
01/2006
Newlin, Heather (Radiation Oncology Resident)Description: Current Status: Outcome:
01/2007
Saito, Aneyuko (Visiting Faculty)Description: Current Status: Outcome:
01/2007
Shi, Wenyin (Radiation Oncology Resident)Description: Current Status: Outcome:
01/2007
Yueng, Anamaria (Radiation Oncology Resident)Description: Current Status: Outcome:
01/2007
Hallemeier, Christopher (Radiation Oncology Resident)Description: Current Status: Outcome:
01/2009 - Present
Wilson, Zachary (Radiation Oncology Resident)Description: Current Status: Outcome:
01/2010 - 01/2014
Park, Sean (Assistant Professor)Description: Current Status: Assistant professorOutcome:
01/2012 - Present
RE-AIMS 09/15/2017
Kenneth R Olivier, MD Page 6 of 23
Presentations ExtramuralNational or International
Invited
Radiation Therapy for Parotid Lymphoma 04/2002American Radium Society
Introduction to Gene Therapy 07/2002American Associtation of Physicists in MedicineMontreal, Quebec, Canada
Introduction to Radiation Oncology 12/03/2004ASCO Multidisciplinary Cancer Management Course
The Lymphomas 03/25/2006
Institutional/Departmental Administrative Responsibilities, Committee Memberships, and Other Activities
Mayo Clinic in Rochester
Assistant Residency Directory
Assistant Residency Director 2010 - 05/15/2013
Department of Radiation Oncology
Regional Practice Committee
Member 2008 - 05/01/2013
Saftey Initiative Group-Radiation Oncology
Member 01/2011 - 06/08/2017
Mayo Clinic in Arizona
Mayo Clinic in Arizona
Department of Education Services
Graduate Medical Education
Active Member 05/2013 - Present
Activities at Other Institutions
Oncology Review Committee
Reviewer - protocol 02/2011 - 05/2013
Academic Career Development
Whitney MacMillan Physician Leadership Business AcademyA business and leadership development series arranged by Mayo to develop future leaders in the institution.Whitney MacMillan Physician Leadership Business AcademyMayo Clinic; Rochester, Minnesota
04/2016 - 09/2016
RE-AIMS 09/15/2017
Kenneth R Olivier, MD Page 7 of 23
ASTRO Review CourseMiami, Florida
IGRT at the University of Floirda 10/13/2006Korean Society of RAdiotherapy and OncologySeoul, South Korea
Lung IGRT at the University of Florida 04/21/2007ASTRO IGRT Symposium
Stereotactic Body Radiotherapy for Spin and Lung Tumors 07/27/2007Japanese Society for Stereotactic RadiotherapyTokyo, Japan
Comparison of Prescription Methods for Stereotactic Body Radiotherapy in Lung Cancer
10/31/2007
ASTRO
Stereotactic Body Radiotherapy at the University of Florida 01/16/2008The Medical CityManila, Philippines
Advanced Stage Lung Cancers 11/03/2010American Society of Theraputic Radiation OncologySan Diego, California
Stereotactic Body Radiotherapy-The Mayo Experience 11/23/2010Spectrum Health Department of Radiation OncologyGrand Rapids, Michigan
Radiotherapy for Melanoma 02/18/2011University of Otago Inaugural International Cancer SymposiumWellington, New Zealand
Stereotactic Body Radiotherapy for Non-Small Cell Lung Cancer 02/18/2011University of Otago Inaugural International Cancer SymposiumWellington, New Zealand
Spine SBRT 03/28/2011Mayo Spine SymposiumNaples, Florida
SBRT for Liver Metastases 11/28/2012RSNA National MeetingChicago, Illinois
SBRT for Soft Tissue and Bone Metastases 12/2013RSNAChicago, Illinois
RE-AIMS 09/15/2017
Kenneth R Olivier, MD Page 8 of 23
SBRT for Bone Metastases 05/12/2014World Congress on Interventional OncologyNew York City, New York
SBRT for focal bone metastases 05/12/2014World Conference on Interventional OncologyNew York, New York
SBRT for pulmonary nodules: trial updates 12/2014RSNAChicago, Illinois
Lung SBRT 02/01/2015Conference on Interventional Oncology (CIO)Miami, Florida
Role for SBRT in the Treatment of Primary Lung Tumors 12/01/2015Radiological Society of North America (RSNA) Assemply and Annual MeetingChicago, Illinois
Locally Advanced Lung Cancer-Discussant 09/28/2016Reviewed and put in context oral presentations at the yearly Radiation Oncology meeting, ASTROASTROBoston, Massachusetts
SBRT for pulmonary nodules 11/29/2016RSNAChicago, Illinois
Oral
Radiation Therapy for Parotid Lymphoma 04/2002Oral PresentationAmerican Radium Society
Introduction to Gene therapy 07/2002American Association of Physicists in Medicine
Process for using Proton Therapy in Spine SBRT 06/10/2015International Stereotactic Radiosurgery Society (ISRS) CongressYokohama, Japan
Poster
Fractionated Radiation Alone Protects C57BL Mice from Challenge with CMT Cells if Challenged within 28 Days from the Completion of Radiation
06/2003
American Society of Gene Therapy
RE-AIMS 09/15/2017
Kenneth R Olivier, MD Page 9 of 23
Fusing Tumor Cell Vaccines Are Potent Immunogens At Least In Part Through The Release of Exosome-like Vesicles Which Load Dendritic Cells With Tumor Antigen
06/2003
American Society of Gene Therapy
Regional
Invited
Radiation and Gene Therapy 05/2001Minnesota Radiologic SocietyMinneapolis, Minnesota
SBRT for Early Lung Cancers 02/200636th Annual University of Florida Radiation Oncology Outcomes Tracking Seminar
Treatment of Early Stage Lung Cancer 09/15/2006Joint Cancer ConferencePalm Beach, Florida
SBRT for Early Lung CAncer at the University of Florida 11/04/2006Florida Society of Clinical OncologyMiami, Florida
Image Guided Radiotherapy 02/23/2007University of Florida Radiation Therapists Convention
Radiotherapy for Metastatic Melanoma 02/23/200737th Annual University of Florida Radiation Oncology Outcomes Tracking Seminar
Different Prescription Methods in Lung SBRT 02/200838th Annual University of Florida Radiation Oncology Outcomes Tracking Seminar
Radioimmunotherapy 02/2008University of Florida Radiation Therapists Convention
Oral
Radiation and Gene Therapy 05/2001Minnesota Radiologic Society
Visiting ProfessorshipVisiting Professorships
Introduction and History of SBRTMayo Clinic Jacksonville
03/28/2011
Visiting Professor In Radiation OncologyMayo Clinic Jacksonville, Department of Radiation Oncology
03/28/2011 - 03/30/2011
RE-AIMS 09/15/2017
Kenneth R Olivier, MD Page 10 of 23
SBRT for Spine and Liver tumorsMayo Clinic Jacksonville
03/29/2011
SBRT for Lung tumorsMayo Clinic Jacksonville
03/30/2011
Visiting ProfessorUniversity of FloridaGainesville, Florida
09/26/2011
Clinical Practice, Interests, and AccomplishmentsStereotactic Body Radiotherapy for primary cancers and aggressive treatment of metastatic disease Lung Cancers.
Research InterestsStereotactic Body Radiotherapy: Co-PI on RTOG 0915 looking at 2 different doses of SBRT for NSCLC. SBRT as immunostimulant in Melanoma Clinical Outcomes of SBRT for all sites Lung Cancer: Clinical treatment and outcomes for Lung CA Funded Research: William Beaumont Hospital, Royal Oak, MI. Research externship. $1500. 1994. Mayo Clinic, Rochester, MN. K12 training grant. $75,000 a year. 2002-2004. University of Florida, Gainesville, FL. MRI motion study in lung cancer (co-PI). State of Florida DOH. $95,000 over 2 years. 2005-2007. University of Florida, Gainesville, FL. External Beam Radiotherapy and Bexxar (PI). Glaxo-Smith-Kline PI initiated protocol. $15,000 in 2007. 2007-current.
Active Grants
Federal
Co-Investigator A Phase II Evaluation of SABR in Oligometastatic Castration-Refractory Prostate Cancer and Immunogenicity of SABR. Funded by National Cancer Institute. (R01 CA 200551)
02/2016 - 01/2019
Industry
Program Director / Principal Investigator
A Randomized Phase III Study of Sublobar Resection (SR) versus Stereotactic Ablative Radiotherapy (SAbR) in High Risk Patients with Stage I Non-Small Cell Lung Cancer (NSCLC): Amendment #1-Internal A Randomized Phase III Study of Sublobar Resection (SR) versus Stereotactic Ablative Radiotherapy (SAbR) in High Risk Patients with Stage I Non-Small Cell Lung Cancer (NSCLC). Funded by Varian Oncology Systems
12/2015 - 11/2022
Research Grants Awarded
RE-AIMS 09/15/2017
Kenneth R Olivier, MD Page 11 of 23
Bibliography
Peer-reviewed Articles
1. Crittenden MR, Gough MJ, Harrington K, Olivier KR, Thompson J, Vile RG. Expression of Inflammatory Cytokines Combines with Local Tumor Destruction Enhances Tumor Regression and Long-term Immunity. Cancer Research. 2002; 63:5505-5512.
2. Kruse JJ, Herman MG, Hagness CR, Davis BJ, Garces YI, Haddock MG, Olivier KR, Stafford SL, Pisansky TM. Electronic and film portal images: A comparison of landmark visibility and review accuracy. Int J Radiat Oncol Biol Phys. 2002 Oct 1; 54(2):584-91. PMID:12243839
3. Linardakis E, Bateman A, Phan V, Ahmed A, Gough M, Olivier K, Kennedy R, Errington F, Harrington KJ, Melcher A, Vile R. Enhancing the efficacy of a weak allogeneic melanoma vaccine by viral fusogenic membrane glycoprotein-mediated tumor cell-tumor cell fusion. Cancer Res. 2002 Oct 1; 62(19):5495-504. PMID:12359759
4. Mora GR, Olivier KR, Cheville JC, Mitchell RF Jr, Lingle WL, Tindall DJ. The cytoskeleton differentially localizes the early growth response gene-1 protein in cancer and benign cells of the prostate. Mol Cancer Res. 2004 Feb; 2(2):115-28. PMID:14985468
5. Olivier KR, Brown PD, Stafford SL, Ansell SM, Martenson JA. Efficacy and treatment-related toxicity of radiotherapy for early-stage primary non-Hodgkin lymphoma of the parotid gland. Int J Radiat Oncol Biol Phys. 2004 Dec 1; 60(5):1510-4. PMID:15590182 DOI:10.1016/j.ijrobp.2004.05.066
6. Mora GR, Olivier KR, Mitchell RF, Jenkins RB, Tindall DJ. Regulation of expression of the early growth response gene-1 (EGR-1) in malignant and benign cells of the prostate. Prostate. 2005 May 1; 63(2):198-207. PMID:15486985 DOI:10.1002/pros.20153
7. * Chang DT, Zlotecki RA, Olivier KR. Re-examining the role of elective nodal irradiation: finding ways to maximize the therapeutic ratio. Am J Clin Oncol. 2005 Dec; 28(6):597-602. PMID:16317271
8. Mendenhall WM, Olivier KR, Lynch JW Jr, Mendenhall NP. Lethal midline granuloma-nasal natural killer/T-cell lymphoma. Am J Clin Oncol. 2006 Apr; 29(2):202-6. PMID:16601443 DOI:10.1097/01.coc.0000198738.61238.eb
9. * Chang DT, Olivier KR, Morris CG, Liu C, Dempsey JF, Benda RK, Palta JR. The impact of heterogeneity correction on dosimetric parameters that predict for radiation pneumonitis. Int J Radiat Oncol Biol Phys. 2006 May 1; 65(1):125-31. Epub 2006 Jan 19. PMID:16427214 DOI:10.1016/j.ijrobp.2005.09.047
10. * Chopra R, Mendenhall WM, Morris CG, Zlotecki RA, Olivier KR. Surgery and postoperative radiotherapy for adenoid cystic carcinoma of the lung. Am J Clin Oncol. 2006 Aug; 29(4):420-1. PMID:16891874 DOI:10.1097/01.coc.0000171280.16889.d0
11. Liauw SL, Yeh AM, Morris CG, Olivier KR, Mendenhall NP. Whole-abdomen radiotherapy for non-Hodgkin's lymphoma using twice-daily fractionation. Int J Radiat Oncol Biol Phys. 2006 Dec 1; 66(5):1440-5. Epub 2006 Sep 25. PMID:16997504 DOI:10.1016/j.ijrobp.2006.07.014
12. * Chang D, Liu C, Dempsey JF, Palta JR, Kopea J, Louis D, Morris C, Chopra R, Olivier KR. Predicting changes in dose distribution to tumor and normal tissue when correcting for heterogeneity in radiotherapy for lung cancer. Am J Clin Oncol. 2007 Feb; 30(1):57-62. PMID:17278896 DOI:10.1097/01.coc.0000251222.36417.3b
RE-AIMS 09/15/2017
Kenneth R Olivier, MD Page 12 of 23
13. Olivier KR, Schild SE, Morris CG, Brown PD, Markovic SN. A higher radiotherapy dose is associated with more durable palliation and longer survival in patients with metastatic melanoma. Cancer. 2007 Oct 15; 110(8):1791-5. PMID:17721993 DOI:10.1002/cncr.22988
14. Vargas C, Mahajan C, Fryer A, Indelicato D, Henderson RH, McKenzie C, Horne D, Chellini A, Lawlor P, Li Z, Oliver K, Keole S. Rectal dose-volume differences using proton radiotherapy and a rectal balloon or water alone for the treatment of prostate cancer. Int J Radiat Oncol Biol Phys. 2007 Nov 15; 69(4):1110-6. PMID:17967305 DOI:10.1016/j.ijrobp.2007.04.075
15. * Chera BS, Olivier K, Morris CG, Lynch JW, Mendenhall NP. Clinical presentation and outcomes of lymphocyte-predominant Hodgkin disease at the University of Florida. Am J Clin Oncol. 2007 Dec; 30(6):601-6. PMID:18091054 DOI:10.1097/COC.0b013e318145b9db
16. Vargas C, Fryer A, Mahajan C, Indelicato D, Horne D, Chellini A, McKenzie C, Lawlor P, Henderson R, Li Z, Lin L, Olivier K, Keole S. Dose-volume comparison of proton therapy and intensity-modulated radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2008 Mar 1; 70(3):744-51. Epub 2007 Sep 27. PMID:17904306 DOI:10.1016/j.ijrobp.2007.07.2335
17. * Yeung AR, Vargas CE, Falchook A, Louis D, Olivier K, Keole S, Yeung D, Mendenhall NP, Li Z. Dose-volume differences for computed tomography and magnetic resonance imaging segmentation and planning for proton prostate cancer therapy. Int J Radiat Oncol Biol Phys. 2008 Dec 1; 72(5):1426-33. Epub 2008 Aug 30. PMID:18762391 DOI:10.1016/j.ijrobp.2008.03.031
18. Saito AI, Li JG, Liu C, Olivier KR, Dempsey JF. Accurate heterogeneous dose calculation for lung cancer patients without high-resolution CT densities. J Appl Clin Med Phys. 2009; 10(2):2847. Epub 2009 Apr 30. PMID:19458588
19. * Chang D, Pacholke H, Amdur R, Mendenhall N, Morris C, Byer G, Olivier KR. Xerostomia in long-term survivors of aggressive non-Hodgkin's lymphoma of Waldeyer's ring: A potential role for parotid-sparing techniques? American Journal of Clinical Oncology. 2009.
20. Markovic SN, Erickson LA, Flotte TJ, Kottschade LA, McWilliams RR, Jakub JW, Farley DR, Tran NV, Schild SE, Olivier KR, Vuk-Pavlovic S, Sekulic A, Weenig RH, Pulido JS, Quevedo JF, Vile RG, Wiseman GA, Stoian I, Pittelkow MR, Melanoma Study. Metastatic malignant melanoma. G Ital Dermatol Venereol. 2009 Feb; 144(1):1-26. PMID:19218908
21. Vargas C, Falchook A, Indelicato D, Yeung A, Henderson R, Olivier K, Keole S, Williams C, Li Z, Palta J. Proton therapy for prostate cancer treatment employing online image guidance and an action level threshold. Am J Clin Oncol. 2009 Apr; 32(2):180-6. PMID:19307953 DOI:10.1097/COC.0b013e3181841f13
22. * Chang DT, Mendenhall NP, Lynch JW, Morris CG, Olivier KR. Long-term outcomes for stage I-II aggressive non-Hodgkin lymphoma of Waldeyer's ring. Am J Clin Oncol. 2009 Jun; 32(3):233-7. PMID:19433961 DOI:10.1097/COC.0b013e318187ddbb
23. * Newlin HE, Iyengar M, Morris CG, Olivier K. Unresectable squamous cell carcinoma of the lung: an outcomes study. Int J Radiat Oncol Biol Phys. 2009 Jun 1; 74(2):370-6. Epub 2009 Apr 06. PMID:19356860 DOI:10.1016/j.ijrobp.2008.08.019
24. Amdur RJ, Bennett J, Olivier K, Wallace A, Morris CG, Liu C, Mendenhall WM. A Prospective, Phase II Study Demonstrating the Potential Value and Limitation of Radiosurgery for Spine Metastases. Am J Clin Oncol. 2009 Jun 12. [Epub ahead of print] PMID:19528790 DOI:10.1097/COC.0b013e318194f70f
25. * Yeung AR, Li JG, Shi W, Newlin HE, Chvetsov A, Liu C, Palta JR, Olivier K. Tumor localization using cone-beam CT reduces setup margins in conventionally fractionated radiotherapy for lung tumors. Int J Radiat Oncol Biol Phys. 2009 Jul 15; 74(4):1100-7. Epub 2009 Apr 22. PMID:19395197 DOI:10.1016/j.ijrobp.2008.09.048
RE-AIMS 09/15/2017
Kenneth R Olivier, MD Page 13 of 23
26. Vargas C, Saito AI, Hsi WC, Indelicato D, Falchook A, Zengm Q, Oliver K, Keole S, Dempsey J. Cine-magnetic resonance imaging assessment of intrafraction motion for prostate cancer patients supine or prone with and without a rectal balloon. Am J Clin Oncol. 2010 Feb; 33(1):11-6. PMID:19730351 DOI:10.1097/COC.0b013e31819fdf7c
27. * Shi W, Liu C, Lu B, Yeung A, Newlin HE, Amdur RJ, Olivier KR. The effect of intravenous contrast on photon radiation therapy dose calculations for lung cancer. Am J Clin Oncol. 2010 Apr; 33(2):153-6. PMID:19806038 DOI:10.1097/COC.0b013e3181a44637
28. * Yeung AR, Li J, Shi W, Newlin H, Morris CG, Samant S, Saito A, Chvetsov A, Liu C, Palta J, Olivier K. Optimal image-guidance scenario with cone-beam computed tomography in conventionally fractionated radiotherapy for lung tumors. Am J Clin Oncol. 2010 Jun; 33(3):276-80. PMID:19841573 DOI:10.1097/COC.0b013e3181aaca41
29. * Shi W, Li JG, Zlotecki RA, Yeung A, Newlin H, Palta J, Liu C, Chvetsov AV, Olivier K. Evaluation of kV cone-beam ct performance for prostate IGRT: a comparison of automatic grey-value alignment to implanted fiducial-marker alignment. Am J Clin Oncol. 2011 Feb; 34(1):16-21. PMID:21189455 DOI:10.1097/COC.0b013e3181d26b1a
30. Stauder MC, Macdonald OK, Olivier KR, Call JA, Lafata K, Mayo CS, Miller RC, Brown PD, Bauer HJ, Garces YI. Early pulmonary toxicity following lung stereotactic body radiation therapy delivered in consecutive daily fractions. Radiother Oncol. 2011 May; 99: (2)166-71. PMID:21571384 DOI:10.1016/j.radonc.2011.04.002
31. Schild SE, Foster NR, Meyers JP, Olivier KR, Ross HJ, Molina JR, Stella PJ, Past LR, Garces YI, Adjei AA, North Central Cancer Treatment Group. Prophylactic cranial irradiation (PCI) in small cell lung cancer (SCLC): Findings from a North Central Cancer Treatment Group (NCCTG) pooled analysis. J Clin Oncol. 2011 May 20; 29: (15_suppl)7074. PMID:28020366
32. * Barney BM, Olivier KR, Miller RC, Haddock MG. Clinical outcomes and toxicity using stereotactic body radiotherapy (SBRT) for advanced cholangiocarcinoma. Radiat Oncol. 2012; 7:67. Epub 2012 May 03. PMID:22553982 PMCID:3464963 DOI:10.1186/1748-717X-7-67
33. * Ahmed KA, Barney BM, Davis BJ, Park SS, Kwon ED, Olivier KR. Stereotactic body radiation therapy in the treatment of oligometastatic prostate cancer. Front Oncol. 2012; 2:215. Epub 2013 Jan 22. PMID:23346551 PMCID:3551203 DOI:10.3389/fonc.2012.00215
34. Foote RL, Stafford SL, Petersen IA, Pulido JS, Clarke MJ, Schild SE, Garces YI, Olivier KR, Miller RC, Haddock MG, Yan E, Laack NN, Arndt CA, Buskirk SJ, Miller VL, Brent CR, Kruse JJ, Ezzell GA, Herman MG, Gunderson LL, Erlichman C, Diasio RB. The clinical case for proton beam therapy. Radiat Oncol. 2012; 7:174. Epub 2012 Oct 22. PMID:23083010 PMCID:3549771 DOI:10.1186/1748-717X-7-174
35. * Smith K, Byer G, Morris CG, Kirwan JM, Lightsey J, Mendenhall NP, Hoppe BS, Lynch J, Olivier K. Outcomes of patients with non-Hodgkin's lymphoma treated with Bexxar with or without external-beam radiotherapy. Int J Radiat Oncol Biol Phys. 2012 Mar 1; 82(3):1122-7. Epub 2011 May 11. PMID:21570217 DOI:10.1016/j.ijrobp.2010.09.044
36. Saito AI, Li JG, Liu C, Olivier KR, Kyougoku S, Dempsey JF. Intravenous contrast agent influence on thoracic computed tomography simulation investigated through a heterogeneous dose calculation method using 5-bulk densities. Am J Clin Oncol. 2012 Apr; 35(2):110-4. PMID:21383608 DOI:10.1097/COC.0b013e318209a910
37. * Ahmed KA, Stauder MC, Miller RC, Bauer HJ, Rose PS, Olivier KR, Brown PD, Brinkmann DH, Laack NN. Stereotactic body radiation therapy in spinal metastases. Int J Radiat Oncol Biol Phys. 2012 Apr 1; 82(5):e803-9. Epub 2012 Feb 11. PMID:22330988 DOI:10.1016/j.ijrobp.2011.11.036
RE-AIMS 09/15/2017
Kenneth R Olivier, MD Page 14 of 23
38. Schild SE, Foster NR, Meyers JP, Ross HJ, Stella PJ, Garces YI, Olivier KR, Molina JR, Past LR, Adjei AA, North Central Cancer Treatment Group. Prophylactic cranial irradiation in small-cell lung cancer: findings from a North Central Cancer Treatment Group Pooled Analysis. Ann Oncol. 2012 Nov; 23: (11)2919-24. PMID:22782333 PMCID:3577038 DOI:10.1093/annonc/mds123
39. Barney BM, Olivier KR, Macdonald OK, Fong de, Miller RC, Haddock MG. Clinical outcomes and dosimetric considerations using stereotactic body radiotherapy for abdominopelvic tumors. Am J Clin Oncol. 2012 Dec; 35(6):537-42. PMID:21659830 DOI:10.1097/COC.0b013e31821f876a
40. Mayo CS, Zankowski C, Herman M, Miller R, Olivier K, Vincent A, Suominen J. A method to vectorize the dose distribution, the dose volume histogram and create a dose vector histogram. Med Phys. 2013 Jan; 40: (1)011717. PMID:23298087 DOI:10.1118/1.4769111
41. * Hallemeier CL, Stauder MC, Miller RC, Garces YI, Foote RL, Sarkaria JN, Bauer HJ, Mayo CS, Olivier KR. Lung stereotactic body radiotherapy using a coplanar versus a non-coplanar beam technique: a comparison of clinical outcomes. Journal of Radiosurgery and SBRT.2013;2:(3):225-233.
42. * G Peacock J, A Call J, R Olivier K. Radiotherapy for metastatic fibrolamellar hepatocellular carcinoma. Rare Tumors. 2013; 5: (3)e28. PMID:24179640 PMCID:3804803 DOI:10.4081/rt.2013.e28
43. * Ahmed KA, Barney BM, Davis BJ, Park SS, Kwon ED, Olivier KR. Stereotactic body radiation therapy in the treatment of oligometastatic prostate cancer. Frontiers in Oncology. 2013; 2 JAN:215.
44. Hallemeier CL, Garces YI, Neben-Wittich MA, Olivier KR, Shon W, Garcia JJ, Brown PD, Foote RL. Adjuvant hypofractionated intensity modulated radiation therapy after resection of regional lymph node metastases in patients with cutaneous malignant melanoma of the head and neck. Pract Radiat Oncol. 2013 Apr-Jun; 3: (2)e71-7. PMID:24674323 DOI:10.1016/j.prro.2012.06.003
45. Seder CW, Allen MS, Cassivi SD, Deschamps C, Nichols FC, Olivier KR, Shen KR, Wigle DA. Stage IIIA non-small cell lung cancer: morbidity and mortality of three distinct multimodality regimens. Ann Thorac Surg. 2013 May; 95(5):1708-16. Epub 2013 Mar 29. PMID:23545194 DOI:10.1016/j.athoracsur.2013.02.041
46. Grams M, de Los Santos LF, Brown L, Olivier K, Brinkmann D. TH-C-137-04: Separating the Dosimetric Consequences of Changing Tumor Anatomy Vs. Positional Uncertainty for Conventionally Fractionated Lung Cancer Patients. Med Phys. 2013 Jun; 40: (6Part32)533. PMID:28517875 DOI:10.1118/1.4815747
47. * Stauder MC, Rooney JW, Neben-Wittich MA, Garces YI, Olivier KR. Late tumor pseudoprogression followed by complete remission after lung stereotactic ablative radiotherapy. Radiat Oncol. 2013 Jul 06; 8: ()167. PMID:23829565 PMCID:3707780 DOI:10.1186/1748-717X-8-167
48. * Barney BM, Markovic SN, Laack NN, Miller RC, Sarkaria JN, Macdonald OK, Bauer HJ, Olivier KR. Increased bowel toxicity in patients treated with a vascular endothelial growth factor inhibitor (VEGFI) after stereotactic body radiation therapy (SBRT). Int J Radiat Oncol Biol Phys. 2013 Sep 01; 87: (1)73-80. PMID:23920388 DOI:10.1016/j.ijrobp.2013.05.012
49. * Ahmed KA, Barney BM, Macdonald OK, Miller RC, Garces YI, Laack NN, Haddock MG, Foote RL, Olivier KR. Stereotactic body radiotherapy in the treatment of adrenal metastases. Am J Clin Oncol. 2013 Oct; 36(5):509-13. PMID:22781389 DOI:10.1097/COC.0b013e3182569189
50. Grams MP, Brown LC, Brinkmann DH, Pafundi DH, Mundy DW, Garces YI, Park SS, Olivier KR, de los Santos LE. Analysis of automatic match results for cone-beam computed tomography localization of conventionally fractionated lung tumors. Pract Radiat Oncol. 2014 Jan-Feb; 4: (1)35-42. PMID:24621421 DOI:10.1016/j.prro.2013.02.008
RE-AIMS 09/15/2017
Kenneth R Olivier, MD Page 15 of 23
51. Mou B, Beltran CJ, Park SS, Olivier KR, Furutani KM. Feasibility of proton transmission-beam stereotactic ablative radiotherapy versus photon stereotactic ablative radiotherapy for lung tumors: a dosimetric and feasibility study. PLoS One. 2014; 9: (6)e98621. PMID:24887068 PMCID:4041776 DOI:10.1371/journal.pone.0098621
52. Saito AI, Olivier KR, Li JG, Liu C, Newlin HE, Schmalfuss I, Kyogoku S, Dempsey JF. Lung tumor motion change during stereotactic body radiotherapy (SBRT): An evaluation using MRI. J appl clin med phys. 2014; 15(3):25-31.
53. Owen D, Olivier KR, Song L, Mayo CS, Miller RC, Nelson K, Bauer H, Brown PD, Park SS, Ma DJ, Garces YI. Safety and Tolerability of SBRT after High-Dose External Beam Radiation to the Lung. Front Oncol. 2014; 4: ()376. PMID:25642416 PMCID:4294121 DOI:10.3389/fonc.2014.00376
54. Brown LC, Lester RA, Grams MP, Haddock MG, Olivier KR, Arndt CA, Rose PS, Laack NN. Stereotactic body radiotherapy for metastatic and recurrent ewing sarcoma and osteosarcoma. Sarcoma. 2014; 2014: ()418270. PMID:25548538 PMCID:4274855 DOI:10.1155/2014/418270
55. * Owen D, Laack NN, Mayo CS, Garces YI, Park SS, Bauer HJ, Nelson K, Miller RW, Brown PD, Olivier KR. Outcomes and toxicities of stereotactic body radiation therapy for non-spine bone oligometastases. Pract Radiat Oncol. 2014 Mar-Apr; 4: (2)e143-9. PMID:24890360 PMCID:4364394 DOI:10.1016/j.prro.2013.05.006
56. * Frechette KM, Brown LC, Aubry MC, Wigle DA, Olivier KR. Pseudoprogression after stereotactic body radiotherapy. J Thorac Oncol. 2014 Apr; 9(4):e29-30. PMID:24736086 DOI:10.1097/JTO.0000000000000067
57. Welch BT, Callstrom MR, Morris JM, Kurup AN, Schmit GD, Weisbrod AJ, Lohse CM, Kohli M, Costello BA, Olivier KR, Thompson RH, Boorjian SA, Atwell TD. Feasibility and oncologic control after percutaneous image guided ablation of metastatic renal cell carcinoma. J Urol. 2014 Aug; 192: (2)357-63. PMID:24631107 DOI:10.1016/j.juro.2014.03.006
58. Sio TT, Jensen AR, Miller RC, de Los Santos LE, Hallemeier CL, Foster NR, Park SS, Bauer HJ, Chang K, Garces YI, Olivier KR. Influence of patient's physiologic factors and immobilization choice with stereotactic body radiotherapy for upper lung tumors. J Appl Clin Med Phys. 2014 Sep; 15: (5)235-245. PMID:28297227 DOI:10.1120/jacmp.v15i5.4931
59. * Sio TT, Jensen AR, Miller RC, Fong de los Santos LE, Hallemeier CL, Foster NR, Park SS, Bauer HJ, Chang K, Garces YI, Olivier KR. Influence of patient's physiologic factors and immobilization choice with stereotactic body radiotherapy for upper lung tumors. J Appl Clin Med Phys. 2014 Sep 08; 15: (5)4931. PMID:25207580
60. Hegg RM, Kurup AN, Schmit GD, Weisbrod AJ, Atwell TD, Olivier KR, Moynihan TJ, Callstrom MR. Cryoablation of sternal metastases for pain palliation and local tumor control. J Vasc Interv Radiol. 2014 Nov; 25(11):1665-70. Epub 2014 Sep 23. PMID:25255705 DOI:10.1016/j.jvir.2014.08.011
61. * Brown LC, Laack TA, Ma DJ, Olivier KR, Laack NN. Multidisciplinary medical simulation: a novel educational approach to preparing radiation oncology residents for oncologic emergent on-call treatments. Int J Radiat Oncol Biol Phys. 2014 Nov 1; 90(3):705-6. Epub 2014 Sep 26. PMID:25304952 DOI:10.1016/j.ijrobp.2014.06.053
62. Grams MP, Fong de Los Santos LE, Brown LC, Mayo CS, Park SS, Garces YI, Olivier KR, Brinkmann DH. Separating the dosimetric consequences of changing tumor anatomy from positional uncertainty for conventionally fractionated lung cancer patients. Pract Radiat Oncol. 2014 Nov-Dec; 4: (6)455-65. PMID:25407869 DOI:10.1016/j.prro.2014.02.006
63. * Owen D, Olivier KR, Mayo CS, Miller RC, Nelson K, Bauer H, Brown PD, Park SS, Ma DJ, Garces YI. Outcomes of stereotactic body radiotherapy (SBRT) treatment of multiple synchronous and recurrent lung nodules. Radiat Oncol. 2015; 10: ()43. PMID:25889747 PMCID:4341868 DOI:10.1186/s13014-015-0340-9
RE-AIMS 09/15/2017
Kenneth R Olivier, MD Page 16 of 23
64. Park SS, Dong H, Liu X, Harrington SM, Krco CJ, Grams MP, Mansfield AS, Furutani KM, Olivier KR, Kwon ED. PD-1 Restrains Radiotherapy-Induced Abscopal Effect. Cancer Immunol Res. 2015 Jun; 3: (6)610-9. PMID:25701325 PMCID:4827718 DOI:10.1158/2326-6066.CIR-14-0138
65. Spiceland CM, Olivier KR, Jatoi A. Radiation-Refractory Brain Metastases in Patients with Non-Small Cell Lung Cancer. J Palliat Med. 2015 Aug; 18: (8)707-10. PMID:26218580 DOI:10.1089/jpm.2015.0097
66. Stish BJ, Hallemeier CL, Olivier KR, Harmsen WS, Allen MS, Garces YI. Long-Term Outcomes and Patterns of Failure After Surgical Resection of Small-Cell Lung Cancer. Clin Lung Cancer. 2015 Sep; 16: (5)e67-73. PMID:25823413 DOI:10.1016/j.cllc.2015.02.004
67. Blanchard M, Shim KG, Grams MP, Rajani K, Diaz RM, Furutani KM, Thompson J, Olivier KR, Park SS, Markovic SN, Pandha H, Melcher A, Harrington K, Zaidi S, Vile R. Definitive Management of Oligometastatic Melanoma in a Murine Model Using Combined Ablative Radiation Therapy and Viral Immunotherapy. Int J Radiat Oncol Biol Phys. 2015 Nov 01; 93: (3)577-87. PMID:26461000 PMCID:4877702 DOI:10.1016/j.ijrobp.2015.07.2274
68. Videtic GM, Hu C, Singh AK, Chang JY, Parker W, Olivier KR, Schild SE, Komaki R, Urbanic JJ, Timmerman RD, Choy H. A Randomized Phase 2 Study Comparing 2 Stereotactic Body Radiation Therapy Schedules for Medically Inoperable Patients With Stage I Peripheral Non-Small Cell Lung Cancer: NRG Oncology RTOG 0915 (NCCTG N0927). Int J Radiat Oncol Biol Phys. 2015 Nov 15; 93: (4)757-64. PMID:26530743 PMCID:4744654 DOI:10.1016/j.ijrobp.2015.07.2260
69. Owen D, Mayo CS, Song L, Ahmed K, Laack N, Olivier K. Dosimetric analysis of varying cord planning organ at risk volume in spine stereotactic body radiation therapy. Adv Radiat Oncol. 2016 Jan-Mar; 1 (1):76-81 Epub 2015 Dec 19 PMID:28799577 PMCID:5506717 DOI:10.1016/j.adro.2015.12.001
70. Ost P, Jereczek-Fossa BA, As NV, Zilli T, Muacevic A, Olivier K, Henderson D, Casamassima F, Orecchia R, Surgo A, Brown L, Tree A, Miralbell R, De Meerleer G. Progression-free Survival Following Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Treatment-naive Recurrence: A Multi-institutional Analysis. Eur Urol. 2016 Jan; 69: (1)9-12. PMID:26189689 DOI:10.1016/j.eururo.2015.07.004
71. Grams MP, Fong de Los Santos LE, Antolak JA, Brinkmann DH, Clarke MJ, Park SS, Olivier KR, Whitaker TJ. Cadaveric verification of the Eclipse AAA algorithm for spine SBRT treatments with titanium hardware. Pract Radiat Oncol. 2016 Mar-Apr; 6: (2)131-41. PMID:26723553 DOI:10.1016/j.prro.2015.10.012
72. * Muldermans JL, Romak LB, Kwon ED, Park SS, Olivier KR. Stereotactic Body Radiation Therapy for Oligometastatic Prostate Cancer. Int J Radiat Oncol Biol Phys. 2016 Jun 01; 95: (2)696-702. PMID:27131082 PMCID:5154616 DOI:10.1016/j.ijrobp.2016.01.032
73. Mayo CS, Pisansky TM, Petersen IA, Yan ES, Davis BJ, Stafford SL, Garces YI, Miller RC, Martenson JA, Mutter RW, Choo R, Hallemeier CL, Laack NN, Ma DJ, Olivier KR, Keole SR, Fatyga M, Foote RL, Haddock MG. Establishment of practice standards in nomenclature and prescription to enable construction of software and databases for knowledge-based practice review. Pract Radiat Oncol. 2016 Jul-Aug; 6: (4)e117-26. PMID:26825250 DOI:10.1016/j.prro.2015.11.001
74. Merrell KW, Mou B, Hallemeier CL, Owen DA, Nelson K, Garces YI, Olivier KR. P1.18: Long-Term Clinical Outcomes and Safety Profile for Central Lung SBRT for NSCLC: Track: Early Stage NSCLC (Stage I - III). J Thorac Oncol. 2016 Oct; 11: (10S)S192. PMID:27676504 DOI:10.1016/j.jtho.2016.08.040
75. Parker WP, Davis BJ, Park SS, Olivier K, Choo CR, Nathan MA, Lowe VJ, Welch TJ, Zaid HB, Sobol II, Tollefson MK, Gettman MT, Boorjian SA, Mynderse LA, Karnes JR, Kwon ED. Patterns of Recurrence Following Primary Radiation Therapy for Prostate Cancer Using C-11 Choline Positron Emission Tomography/Computed Tomography: Unique Identification of Sites of Recurrence Impacting Clinical Management. Int J Radiat Oncol Biol Phys. 2016 Oct 1; 96: (2S)S112. PMID:27675554 DOI:10.1016/j.ijrobp.2016.06.276
RE-AIMS 09/15/2017
Kenneth R Olivier, MD Page 17 of 23
76. Evans JD, Davis BJ, Stish BJ, Park SS, Olivier K, Choo CR, Nathan MA, Welch BT, Karnes RJ, Mynderse LA, Pisansky TM, Kwon ED, Lowe VJ. Recurrence Patterns of Oligometastatic Disease Detected Using C-11 Choline Positron Emission Tomography/Computed Tomography in Patients With a Rising Prostate-Specific Antigen Level Following Postprostatectomy Radiation Therapy. Int J Radiat Oncol Biol Phys. 2016 Oct 1; 96: (2S)S103. PMID:27675532 DOI:10.1016/j.ijrobp.2016.06.255
77. Haddad MM, Merrell KW, Hallemeier CL, Johnson GB, Mounajjed T, Olivier KR, Fidler JL, Venkatesh SK. Stereotactic body radiation therapy of liver tumors: post-treatment appearances and evaluation of treatment response: a pictorial review. Abdom Radiol (NY). 2016 Oct; 41: (10)2061-77. PMID:27167232 DOI:10.1007/s00261-016-0768-x
78. Breen WG, Merrell KW, Mansfield AS, Wigle DA, Garces YI, Park SS, Olivier KR, Hallemeier CL. Predictors of relapse and evaluation of the role of postoperative radiation therapy in a modern series of patients with surgically resected stage III (N2) non-small cell lung cancer. Adv Radiat Oncol. 2017 Jan-Mar; 2: (1)12-18. PMID:28740911 PMCID:5514239 DOI:10.1016/j.adro.2016.12.004
79. Parker WP, Davis BJ, Park SS, Olivier KR, Choo R, Nathan MA, Lowe VJ, Welch TJ, Evans JD, Harmsen WS, Zaid HB, Sobol I, Moreira DM, Haloi R, Tollefson MK, Gettman MT, Boorjian SA, Mynderse LA, Karnes RJ, Kwon ED. Identification of Site-specific Recurrence Following Primary Radiation Therapy for Prostate Cancer Using C-11 Choline Positron Emission TomographyComputed Tomography: A Nomogram for Predicting Extrapelvic Disease. Eur Urol. 2017 Mar; 71: (3)340-348. PMID:27597240 DOI:10.1016/j.eururo.2016.08.055
80. Parker WP, Evans JD, Stish BJ, Park SS, Olivier K, Choo R, Nathan MA, Welch BT, Karnes RJ, Mynderse LA, Pisansky TM, Kwon ED, Lowe VJ, Davis BJ. Patterns of Recurrence After Postprostatectomy Fossa Radiation Therapy Identified by C-11 Choline Positron Emission Tomography/Computed Tomography. Int J Radiat Oncol Biol Phys. 2017 Mar 01; 97: (3)526-535. PMID:28126302 PMCID:5308881 DOI:10.1016/j.ijrobp.2016.11.014
81. Youland RS, Packard AT, Blanchard MJ, Arnett AL, Wiseman GA, Kottschade LA, Dronca RS, Markovic SN, Olivier KR, Park SS. 18F-FDG PET response and clinical outcomes after stereotactic body radiation therapy for metastatic melanoma. Adv Radiat Oncol. 2017 Apr-Jun; 2: (2)204-210. PMID:28740933 PMCID:5514257 DOI:10.1016/j.adro.2017.02.003
82. Arnett AL, Packard AT, Mara K, Mansfield AS, Wigle DA, Haddock MG, Park SS, Olivier KR, Garces YI, Merrell KW. FDG-PET parameters as predictors of pathologic response and nodal clearance in patients with stage III non-small cell lung cancer receiving neoadjuvant chemoradiation and surgery. Pract Radiat Oncol. 2017 Apr 19; : (). PMID:28733185 DOI:10.1016/j.prro.2017.04.013
83. Henkle E, Aksamit TR, Barker AF, Curtis JR, Daley CL, Anne Daniels ML, DiMango A, Eden E, Fennelly K, Griffith DE, Johnson M, Knowles MR, Leitman A, Leitman P, Malanga E, Metersky ML, Noone PG, O'Donnell AE, Olivier KN, Prieto D, Salathe M, Thomashow B, Tino G, Turino G, Wisclenny S, Winthrop KL. Pharmacotherapy for Non-Cystic Fibrosis Bronchiectasis: Results From an NTM Info & Research Patient Survey and the Bronchiectasis and NTM Research Registry. Chest. 2017 May 05; : (). PMID:28479113 DOI:10.1016/j.chest.2017.04.167
RE-AIMS 09/15/2017
Kenneth R Olivier, MD Page 18 of 23
Book Chapters
1. Moore-Higgs GJ, Olivier KR. New advances in radiotherapy for lung cancer. In: Haas ML editor. Contemporary issues in lung cancer: a nursing perspective. 2nd Edition. Sudbury: Jones and Bartlett Publishers; 2010. p. 107-15.
2. Olivier KR, Garces YI. Radiotherapy for the Locally Advanced Non-Small Cell Lung Cancer. In: Schild SE. Thoracic Malignancies: Radiation Medicine Rounds. 1st ed. Vol. 1. New York: demosMedical; 2010. p. 21-38.
3. Olivier K. Academic comment. In: Small W Jr; Williams TR; Donnelly ED editor. Radiation oncology: difficult cases and practical management. New York: Demos Medical; 2013. p. 181-4.
Letters
1. Olivier KR. Radiotherapy for MALT lymphoma. Mayo Clin Proc. 2004 Feb; 79(2):276. PMID:14959927 DOI:
2. Grams MP, Fong de Los Santos LE, Brown LC, Mayo CS, Park SS, Garces YI, Olivier KR, Brinkmann DH. In Reply to Yartsev and Chen. Pract Radiat Oncol 2015 Sep-Oct; 5 (5):e555 PMID:26362711 DOI:10.1016/j.prro.2015.02.004
Abstracts
1. Olivier K, Kottke T, Bateman A, Harrington K, Linardakis E, Ahmed A, Gough M, Riddle D, Peterson T, Simari R, Melcher A, Vile R. Fusing tumor cell vaccines are potent immunogens at least in part through the release of exosome-like vesicles which load dendritic cells with tumor antigen. Mol Ther. 2003 May; 7(5):S276.
2. Mora GR, Olivier KR, Mitchell RF Jr, Cheville JC, Lingle WL, Tindall DJ. The cytoskeleton differentially localizes the early growth response gene-1 (EGR-1) in cancer and benign cells of the prostate. Proceedings American Association for Cancer Research Annual Meeting. 2003 Jul; 44:261.
3. MacDonald OK, Kazemba B, Olivier KR, Brown PD, Miller RC, Fong de Los Santos L, Garces YL. Comparative analysis of coplanar vs. noncoplanar planning approaches in extra-cranial stereotactic radiotherapy (SBRT) of early stage peripheral non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys. 2009; 75(Suppl S):S686-7.
4. Stauder MC, MacDonald OK, Olivier KR, Miller RC, Brown PD, Garces YI. Early pulmonary toxicity of lung stereotactic body radiation therapy (SBRT) delivered as consecutive daily fractions. Int J Radiat Oncol Biol Phys. 2010; 78(Suppl S):S182-3.
5. Woltman NM, Garces Y, Olivier K, Miller R. Incidence of radiation pneumonitis after thoracic intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2010; 78(Suppl S):S738.
6. Smith KB, Byer G, Morris CG, Kirwan JM, Lightsey J, Mendenhall NP, Hoppe BS, Lynch JW, Olivier K. Outcomes of patients with non-Hodgkin's lymphoma treated with Bexxar with or without external-beam radiotherapy. Int J Radiat Oncol Biol Phys. 2010; 78(Suppl S):S551.
7. Barney BM, Olivier KR, Wilson ZC, Miller RC, Macdonald OK, Brown PD, Foote RL, Markovic SN. Clinical outcomes and toxicity using stereotactic body radiotherapy (SBRT) for stage IV melanoma. Int J Radiat Oncol Biol Phys. 2011; 81(S):S687.
8. Ahmed KA, Stauder MC, Miller RC, Bauer HJ, Olivier KR, Laack NN. Clinical outcomes of single and multifractionated SBRT schedules for spinal metastases. Int J Radiat Oncol Biol Phys. 2011; 81(S):S292-3.
RE-AIMS 09/15/2017
Kenneth R Olivier, MD Page 19 of 23
9. Stauder MC, Olivier KR, Macdonald OK, Lafata K, Mayo CS, Bauer HJ, Miller RC, Brown PD, Garces YI. Maximum PTV dose predicts for radiation pneumonitis following lung stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2011; 81(S):S614.
10. Barney B, Olivier K, Miller R, Fong de los Santos L, Haddock M. Clinical outcomes and toxicity using stereotactic body radiotherapy (SBRT) for non-liver abdominal cavity tumors. American Journal Of Clinical Oncology-cancer Clinical Trials. 2011 Apr; 34(2):196.
11. Khwaja S, Barney B, Olivier K, Miller R, Haddock M. Clinical outcomes using stereotactic body radiation therapy (SBRT) for metastases to retroperitoneal lymph nodes. American Journal Of Clinical Oncology-cancer Clinical Trials. 2011 Apr; 34(2):206.
12. Hallemeier C, Stauder M, Miller R, Garces Y, Foote R, Bauer H, Lafata K, Mayo C, Olivier K. Lung stereotactic body radiotherapy using coplanar versus non-coplanar beam arrangements: a comparison of clinical outcomes. American Journal Of Clinical Oncology-cancer Clinical Trials. 2012 Apr; 35(2):201.
13. Schild SE, Hillman S, Graham D, Vora S, Garces Y, Olivier K, Kugler J, Ross H, Molina J, Adjei A. Long-term survival of patients(pts) treated with high-dose radiotherapy(rt) & concurrent chemotherapy for unresectable non-small cell lung cancer(nsclc). J Thorac Oncol. 2012 Sep; 7(9):S234.
14. Stauder MC, Roden AC, Wigle D, Price KA, Garces YI, Olivier KR. Radiologic tumor regression and correlation with pathologic findings after neoadjuvant therapy for non-small cell lung cancer. J Thorac Oncol. 2012 Sep; 7(9):S226.
15. Sio TT, Jensen AR, Fong de los Santos LE, Park SS, Hallemeier CL, Ma DJ, Bauer HJ, Olivier KR. S-frame versus bodyfix: a comparison of immobilization techniques for upper lung tumors with stereotactic body radiotherapy. J Thorac Oncol. 2012 Sep; 7(9):S265.
16. Hallemeier CL, Garces YI, Neben-Wittich MA, Olivier KR, Garcia JA, Brown PD, Foote RL. Adjuvant hypofractionated intensity modulated radiation therapy (imrt) after resection of regional lymph node (ln) metastases in patients with malignant melanoma of the head and neck. Int J Radiat Oncol Biol Phys. 2012 Nov 1; 84(3):S505-6.
17. Barney BM, Haddock MG, Miller RC, Olivier KR. Clinical outcomes and toxicity using stereotactic body radiation therapy (sbrt) for advanced cholangiocarcinoma. Int J Radiat Oncol Biol Phys. 2012 Nov 1; 84(3):S325.
18. Stauder MC, Roden AC, Wigle D, Price KA, Garces YI, Olivier KR. Radiologic tumor regression and correlation with pathologic findings after neoadjuvant therapy for non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2012 Nov 1; 84(3):S548-9.
19. Ahmed K, Park SS, Kwon ED, Olivier KR. Role of stereotactic body radiation therapy in oligometastatic, hormone refractory prostate cancer. Int J Radiat Oncol Biol Phys. 2012 Nov 1; 84(3):S360.
20. Sio TT, Jensen AR, Fong de los Santos LE, Park SS, Hallemeier CL, Ma DJ, Bauer HJ, Olivier KR. S-frame versus dual vacuum: a comparison of immobilization techniques for upper lung tumors with stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys. 2012 Nov 1; 84(3):S726.
21. Mayo C, Zankowski C, Herman M, Miller R, Olivier K, Suominen J. A method to vectorize the dose distribution, the dose volume histogram (Abstract SUâ€Eâ€Tâ€487) Medical Physics. 2013; 40: (6)318.
RE-AIMS 09/15/2017
Kenneth R Olivier, MD Page 20 of 23
22. Grams M, Fong de Los Santos L, Brown L, Olivier K, Brinkmann D. Separating the dosimetric consequences of changing tumor anatomy vs. positional uncertainty for conventionally fractionated lung cancer patients (Abstract THâ€Câ€137â€04) Medical Physics. 2013; 40: (6)533.
23. Merrell KW, Barney BM, Yan E, Laack NN, Olivier KR. A comparison of standard fractionation and stereotactic body radiation therapy in the treatment of metastatic breast cancer. Int J Radiat Oncol Biol Phys. 2013 Oct 1; 87(2):S232-3.
24. Merrell KW, Barney BM, Park SS, Laack NN, Haddock MG, Miller RC, Olivier KR. An institutional review of stereotactic body radiation therapy for liver tumors. Int J Radiat Oncol Biol Phys. 2013 Oct 1; 87(2):S322-3.
25. Owen D, Mayo C, Ahmed K, Laack N, Olivier K. Cord and thecal sac dosimetric correlation with toxicity for spine sbrt. Int J Radiat Oncol Biol Phys. 2013 Oct 1; 87(2):S55-6.
26. Owen D, Laack NN, Mayo C, Garces YI, Park S, Bauer HJ, Nelson K, Miller RW, Brown PD, Olivier KR. Outcomes and toxicities of stereotactic body radiation therapy (sbrt) for nonspine osseous oligometastases. Int J Radiat Oncol Biol Phys. 2013 Oct 1; 87(2):S724.
27. Videtic GM, Hu C, Singh A, Chang JY, Parker W, Olivier K, Schild S, Komaki R, Urbanic J, Choy H. Radiation therapy oncology group (rtog) protocol 0915: a randomized phase 2 study comparing 2 stereotactic body radiation therapy (sbrt) schedules for medically inoperable patients with stage i peripheral non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2013 Oct 1; 87(2):S3.
28. Brown LC, Lester RA, Haddock MG, Sarkaria JN, Olivier KR, Arndt CAS, Laack NN. Stereotactic body radiation therapy (sbrt) for pediatric bone tumors. Int J Radiat Oncol Biol Phys. 2013 Oct 1; 87(2):S71.
29. Barney BM, Callstrom MR, Merrell KW, Hardie JG, Olivier KR. Stereotactic body radiation therapy after other minimally-invasive local therapies for liver tumors. Int J Radiat Oncol Biol Phys. 2013 Oct 1; 87(2):S316.
30. Videtic G, Hu C, Singh A, Chang J, Parker W, Olivier K, Schild S, Komaki R, Urbanic J, Choy H. Radiation therapy oncology group (rtog) protocol 0915: a randomized phase ii study comparing 2 stereotactic body radiation therapy (sbrt) schedules for medically inoperable patients (pts) with stage i peripheral non-small cell lung cancer. J Thorac Oncol. 2013 Nov; 8:S170.
31. Blanchard MJ, Zaidi S, Grams M, Shim K, Rajani K, Diaz R, Furutani K, Olivier K, Park S, Vile R. Definitive management of oligometastatic melanoma in a murine model using combined ablative radiation therapy (sabr) and viroimmunotherapy (vi). Int J Radiat Oncol Biol Phys. 2014 Sep 1; 90:S57.
32. Merrell KW, Francis SR, Mou B, Hallemeier CL, Olivier KR. Outcomes and prognostic factors of stereotactic body radiation therapy for soft-tissue sarcoma metastases. Int J Radiat Oncol Biol Phys. 2014 Sep 1; 90:S765-6.
33. Park SS, Dong H, Zhao W, Grams MP, Liu X, Harrington SM, Furutani KM, Krco CJ, Olivier KR, Markovic SN, Kwon ED. Pd-1 blockade enhances radiation therapy-induced abscopal effect. Int J Radiat Oncol Biol Phys. 2014 Sep 1; 90:S57-8.
34. Shaffer J, Feng MU, Pollom E, Stenmark MH, Tang M, Monroe AT, Lee P, Merrell KW, Olivier KR, Koong AC, Chang DT. Pooled analysis of liver stereotactic body radiation therapy for colorectal metastases: results from 5 institutions. Int J Radiat Oncol Biol Phys. 2014 Sep 1; 90:S376.
RE-AIMS 09/15/2017
Kenneth R Olivier, MD Page 21 of 23
35. Chang DT, Shaffer J, Pollom E, Stenmark MH, Tang M, Merrell KW, Lee P, Olivier KR, Koong AC, Feng MU. Pooled analysis of liver stereotactic body radiation therapy for hepatocellular carcinoma: results from a multi-institution study. Int J Radiat Oncol Biol Phys. 2014 Sep 1; 90:S376.
36. Shaffer J, Feng MU, Pollom E, Stenmark MH, Tang M, Monroe AT, Merrell KW, Lee P, Olivier KR, Koong AC, Chang DT. Pooled analysis of stereotactic body radiation therapy for liver tumors: results from 5 institutions. Int J Radiat Oncol Biol Phys. 2014 Sep 1; 90:S380-1.
37. Owen D, Mayo CS, Song LS, Ahmed K, Laack NN, Olivier KR. Pushing the dose to the spinal cord in spine sbrt - cord and thecal sac dosimetric correlation with toxicity. Int J Radiat Oncol Biol Phys. 2014 Sep 1; 90:S25.
38. Merrell K, Seder C, Mou B, Wilson Z, Hallemeier C, Olivier K, Wigle D, Garces Y. Radiation dose response and clinical outcomes with trimodality therapy for stage iiia non-small cell lung cancer. J Thorac Oncol. 2014 Sep; 9(9):S156-7.
39. Mou B, Merrell KW, Owen DA, Nelson KE, Garces YI, Olivier KR. Stereotactic body radiation therapy for central lung tumors: outcomes and toxicity. Int J Radiat Oncol Biol Phys. 2014 Sep 1; 90:S623.
40. Vu CC, Sio TT, Chang K, Miller RC, Garces YI, Park SS, Nelson KE, Sloan JA, Olivier KR. Baseline patient-reported quality of life is not related to overall survival in patients receiving stereotactic body radiation therapy for thoracic malignancies: a preliminary report. Int J Radiat Oncol Biol Phys. 2014 Nov 15; 90:S59.
41. Mou B, Merrell KW, Owen DA, Nelson KE, Garces YI, Olivier KR. Stereotactic body radiation therapy for central lung tumors: outcomes and toxicity. Int J Radiat Oncol Biol Phys. 2014 Nov 15; 90:S80.
42. Breen W, Merrell K, Mansfield A, Wigle D, Garces Y, Olivier K, Hallemeier C. Predictors of relapse and evaluation of post-operative radiotherapy in patients with resected stage iii (n2) non-small cell lung cancer Journal Of Thoracic Oncology. 2015 Sep; 10: (9)S574.
43. Youland RS, Blanchard MJ, Markovic SN, Olivier K, Park SS. A comparison of stereotactic body radiation therapy (sbrt) versus conventional/hypofractionated radiation therapy (chrt) for metastatic malignant melanoma (mm) International Journal Of Radiation Oncology Biology Physics. 2015 Nov 1; 93: (3)E629-30.
44. Grams M, Clarke M, Antolak JA, Brinkmann DH, Fong de los Santos L, Mayo C, Park SS, Olivier K, Whitaker TJ. Cadaveric verification of vmat dose distributions for spine sbrt treatments with titanium implants International Journal Of Radiation Oncology Biology Physics. 2015 Nov 1; 93: (3)E547-8.
45. Park SS, Dong H, Harrington S, Grams M, Mansfield AS, Furutani KM, Olivier K, Kwon ED. Cd11a(high)cd8(+) t cell phenotype identifies tumor specific effector cells whose frequency and function are enhanced by rt International Journal Of Radiation Oncology Biology Physics. 2015 Nov 1; 93: (3)S96.
46. Hobbs CJ, Ko S, Paryani NN, Olivier K, Garces Y, Park SS, Hallemeier CL, Schild SE, Vora S, Ashman J, Rule WG, Bowers JR, Heckman MG, Diehl NN, Miller RC. Stereotactic body radiation therapy (sbrt) for early-stage non$132#small cell lung cancer (nsclc) and impact of maximum standardized uptake value (suvmax), biologically effective dose (bed), and mediastinal staging on prognosis International Journal Of Radiation Oncology Biology Physics. 2015 Nov 1; 93: (3)S102.
47. Shiraishi S, Grams MP, Antolak JA, Park SS, Olivier KR, Garces YI, Fong LE. Experimental Verification of Eclipse AAA and Acuros Lung Dose Calculations Journal of Applied Clinical Medical Physics.2017 May 15;18:(3)227. Abstract no.PO-BPC-Exhibit Hall-10.
RE-AIMS 09/15/2017
Kenneth R Olivier, MD Page 22 of 23
* Indicates that the primary author was a mentee of this author.
Kenneth R Olivier, MD Page 23 of 23
top related